siRNA-Mediated Silencing of CIP2A Enhances Docetaxel Activity Against PC-3 Prostate Cancer Cells

Purpose: Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an identified human oncoprotein which modulates malignant cell growth. It is overexpressed in human prostate cancer and in most of the human malignancies. The aim of this study was to investigate the effects of CIP2A silencing on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Razi Soofiyani, Saiedeh, Mohammad Hoseini, Akbar, Mohammadi, Ali, Khaze Shahgoli, Vahid, Baradaran, Behzad, Hejazi, Mohammad Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788219/
https://www.ncbi.nlm.nih.gov/pubmed/29399554
http://dx.doi.org/10.15171/apb.2017.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788219/
https://www.ncbi.nlm.nih.gov/pubmed/29399554
http://dx.doi.org/10.15171/apb.2017.076

Ejemplares similares